On 05 February 2016
Plethico Pharmaceuticals announced that the Board of Directors vide its resolution dated 05 February 2016 have approved the following:1. Appointment of Milindkumar Laxmishankar Dixit as an Independent Director (Additional Director) on the Board of the Company for a period of five years with effect from 05 February 2016 subject to approval of the members at the ensuing General Meeting.
2. Acceptance of Resignation given by Chirag Patel as Whole time director of the Company. Chirag Patel has resigned with effect from 05 February 2016 from the position of Whole Time Director of the Company.
3. Adoption of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) including authorizing Shashikant Patel, Chairman and Managing Director of the Company to enter into amended Listing Agreement and submission of the same to BSE and any other applicable authorities, if required.
4. The re-constitution of Committees.
5. As per section 178 of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Remuneration Committee has been renamed with Nomination and remuneration Committee w.e.f. 05 February 2016.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
